NEWS & Digital Library
Will the House of
Representatives Let Jeff
Sessions Shut Down
Medical Marijuana?
Thursday ,29 June 2017
By Justin Strekal, NORML, Political Director
This week, the House Appropriations Committee released its 2018 Commerce, Justice, Science (CJS) Appropriations bill, which determines the funding levels for numerous federal agencies, including the Department of Justice. Predictably, the bill does not include language — known as the Rohrabacher-Blumenauer amendment — limiting the Justice Department from taking action against state-sanctioned medical cannabis producers, retailers, or consumers.
Although the amendment was reauthorized by Congress in May, US Attorney General Jeff Sessions has been aggressively lobbying leadership to ignore the provisions. President Trump also issued a signing statement objecting to the Rohrbacher-Blumenauer provision.
67
Study: Medical Marijuana Legalization Linked
To Lower Medicaid Costs
Friday, 21 April 2017 | by Paul Armentano, NORML Deputy Director
Patients use fewer prescription drugs in states where access to medical cannabis is legally regulated, according to data published in the journal Health Affairs.